Renaissance Technologies - ANPAC BIO MED SCIENCE CO LTD ownership

Back to all holdings Add to watchlist

ANPAC BIO MED SCIENCE CO LTD's ticker is ANPC and the CUSIP is 03635R107. A total of 7 filers reported holding ANPAC BIO MED SCIENCE CO LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of ANPAC BIO MED SCIENCE CO LTD
ValueSharesWeighting
Q2 2022$18,000
-5.3%
62,352
+297.1%
0.00%–
Q4 2021$19,000
-95.6%
15,700
-78.2%
0.00%
-100.0%
Q1 2021$431,000
+459.7%
71,938
+392.1%
0.00%–
Q4 2020$77,000–14,620–0.00%–
 Download
Other shareholders
ANPAC BIO MED SCIENCE CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
HBK Sorce Advisory LLC 19,126$81,0000.00%
TWO SIGMA SECURITIES, LLC 15,677$66,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 116,628$491,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 17,284$73,0000.00%
Tower Research Capital LLC (TRC) 1,177$5,0000.00%
UBS Group AG 2,765$12,0000.00%
View complete list of ANPAC BIO MED SCIENCE CO LTD shareholders